Serenoa repens associated with Urtica dioica (ProstaMEV®) and curcumin and quercitin (FlogMEV®) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study

International Journal of Antimicrobial Agents

Volumn 33, Issue 6, 2009, Pages 549-553

  Cai, Tommaso ^a   Mazzoli, Sandra ^b   Bechi, Adriano ^b   Addonisio, Patrizia ^b   Mondaini, Nicola ^a   Pagliai, Roberto Castricchi ^b   Bartoletti, Riccardo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

Curcumin; Prostatitis; Prulifloxacin; Quercitin; Quinolones; Serenoa repens; Urtica dioica

Indexed keywords

ANTIBIOTIC AGENT; CURCUMIN; FLOGMEV; PLACEBO; PROSTAMEV; PRULIFLOXACIN; QUERCETIN; QUINOLONE DERIVATIVE; SABAL EXTRACT; UNCLASSIFIED DRUG; URTICA DIOICA EXTRACT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CHRONIC BACTERIAL PROSTATITIS; CHRONIC PROSTATITIS; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SCREENING; FOLLOW UP; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SABAL; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URTICA DIOICA;

ADULT; ANTI-BACTERIAL AGENTS; CURCUMIN; DIOXOLANES; FLAVONOIDS; FLUOROQUINOLONES; FOLLOW-UP STUDIES; HUMANS; MALE; PIPERAZINES; PROSPECTIVE STUDIES; PROSTATITIS; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; SERENOA; TREATMENT OUTCOME; URTICA DIOICA; YOUNG ADULT;

EID: 64549104596     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.11.012     Document Type: Article

References (36)

1. Wagenlehner F.M., Diemer T., Naber K.G., and Weidner W. Chronic bacterial prostatitis (NIH type II): diagnosis, therapy and influence on the fertility status. Andrologia 40 (2008) 100-104
2. Mazzoli S. Conventional bacteriology in prostatitis patients: microbiological bias, problems and epidemiology on 1686 microbial isolates. Arch Ital Urol Androl 79 (2007) 71-75
3. Nickel J.C., and Xiang J. Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis. J Urol 179 (2008) 1391-1395
4. Skerk V., Sternak S.L., Roglić S., Skerk V., and Lisi M. Diagnosis and treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 17 (2005) 570-571
5. Naber K.G. Management of bacterial prostatitis: what's new?. BJU Int 101 Suppl. 3 (2008) 7-10
6. Han C.H., Yang C.H., Sohn D.W., Kim S.W., Kang S.H., and Cho Y.H. Synergistic effect between lycopene and ciprofloxacin on a chronic bacterial prostatitis rat model. Int J Antimicrob Agents 31 Suppl. 1 (2008) S102-S107
7. Nickel J.C. Antibiotics for bacterial prostatitis. J Urol 163 (2000) 1407
8. Stamey T.A., Meares E.M., and Winningham D.G. Chronic bacterial prostatitis and diffusion of drugs into prostatic fluid. J Urol 103 (1970) 187-194
9. Lee Y.S., Han C.H., Kang S.H., Lee S.J., Kim S.W., Shin O.R., et al. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model. Int J Urol 12 (2005) 383-389
10. Wagenlehner F.M., Weidner W., Sörgel F., and Naber K.G. The role of antibiotics in chronic bacterial prostatitis. Int J Antimicrob Agents 26 (2005) 1-7
11. Magri V., Trinchieri A., Pozzi G., Restelli A., Garlaschi M.C., Torresani E., et al. Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis. Int J Antimicrob Agents 29 (2007) 549-556
12. Wilt T., Mac Donald R., Ishani A., Rutks I., and Stark G. Cernilton for benign prostatic hyperplasia. Cochrane Database Syst Rev (2000) CD001042
13. Vanderhoof J.A. Probiotics: future directions. Am J Clin Nutr 73 (2001) 1152S-1155S
14. Shoskes D.A. Phytotherapy in chronic prostatitis. Urology 60 (2002) 35-37
15. Shoskes D.A., Hakim L., Ghoniem G., and Jackson C.L. Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol 69 (2003) 1406-1410
16. Shoskes D.A. Use of the bioflavonoid quercetin in patients with longstanding chronic prostatitis. J Am Neutraceutical Assoc 2 (1999) 18
17. Sato M., Miyazaki T., Kambe F., Maeda K., and Seo H. Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 24 (1997) 1680-1684
18. Chen Z.Q., and Mo Z.N. Curcumin in the treatment of prostatic diseases. Zhonghua Nan Ke Xue 14 (2008) 67-70
19. Chrubasik J.E., Roufogalis B.D., Wagner H., and Chrubasik S. A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: Urticae radix. Phytomedicine 14 (2007) 568-579
20. Naber K.G., Bergman B., Bishop M.C., Bjerklund-Johansen T.E., Botto H., Lobel B., et al., Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). EAU guidelines for the management of urinary and male genital tract infections. Eur Urol 40 (2001) 576-588
21. Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., and Stamm W.E. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 15 Suppl. 1 (1992) S216-S227
22. Trinchieri A. Role of levofloxacin in the treatment of urinary tract infections. Arch Ital Urol Androl 73 (2001) 105-113
23. Mehlhorn A.J., and Brown D.A. Safety concerns with fluoroquinolones. Ann Pharmacother 41 (2007) 1859-1866
24. Fiamegos Y.C., Nanos C.G., Vervoort J., and Stalikas C.D. Analytical procedure for the in-vial derivatization-extraction of phenolic acids and flavonoids in methanolic and aqueous plant extracts followed by gas chromatography with mass-selective detection. J Chromatogr A 1041 (2004) 11-18
25. Motrich R.D., Cuffini C., Mackern Oberti J.P., Maccioni M., and Rivero V.E. Chlamydia trachomatis occurrence and its impact on sperm quality in chronic prostatitis patients. J Infect 53 (2006) 175-183
26. Mazzoli S., Cai T., Rupealta V., Gavazzi A., Castricchi Pagliai R., Mondaini N., et al. Interleukin 8 and anti-Chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection. Eur Urol 51 (2007) 1385-1393
27. Giubilei G., Mondaini N., Crisci A., Raugei A., Lombardi G., Travaglini F., et al. The Italian version of the National Institutes of Health Chronic Prostatitis Symptom Index. Eur Urol 47 (2005) 805-811
28. Badia X., Garcia-Losa M., and Dal-Re R. Ten-language translation and harmonization of the International Prostate Symptom Score: developing a methodology for multinational clinical trials. Eur Urol 31 (1997) 129-140
29. Bartoletti R., Mondaini N., Pavone C., Dinelli N., and Prezioso D. Introduction to chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS). Arch Ital Urol Androl 79 (2007) 55-57
30. Magri V., Trinchieri A., Ceriani I., Marras E., and Perletti G. Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome. Arch Ital Urol Androl 79 (2007) 93-98
31. Boots A.W., Wilms L.C., Swennen E.L., Kleinjans J.C., Bast A., and Haenen G.R. In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition 24 (2008) 703-710
32. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 9 (2003) 161-168
33. Menon V.P., and Sudheer A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 595 (2007) 105-125
34. Gerber G.S. Saw palmetto for the treatment of men with lower urinary tract symptoms. J Urol 163 (2000) 1408-1412
35. Bundrick W., Heron S.P., Ray P., Schiff W.M., Tennenberg A.M., Wiesinger B.A., et al. Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study. Urology 62 (2003) 537-541
36. Bjerklund Johansen T.E., Grüneberg R.N., Guibert J., Hofstetter A., Lobel B., Naber K.G., et al. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol 34 (1998) 457-466